Abstract:To define cellular factors involved in the life cycle of influenza virus, we have used a genome-wide yeast-two-hybrid screening approach. Interestingly, we have identified a novel interaction between the 54 amino-acid cytosolic tail of influenza A virus M2 proton channel protein and the cyclin D3 cellular protein, a key regulator of the cell cycle G1-S transition. Very little is known about crosstalks between influenza A virus and the cellular machineries that regulate the cell cycle. We confirmed the physical interaction between M2 and Cyclin D3, by co-immunoprecipitation studies in human epithelial cells. We then conducted immunofluorescence assays to analyze the relative distribution of cyclin D3 and M2 in infected A549 lung epithelial cells. Interestingly, we observed that cyclin D3 is relocated to or retained at the Golgi apparatus, where M2 is concentrated, at 5 hours post infection. In contrast, cyclin D3 was mainly present in the nucleus, with occasional localization in the cytoplasm, in non-infected cells. More importantly, at 10 hours post infection cyclin D3 was detected in the cytoplasm and at 24 hours post infection expression levels were much reduced. To further study the consequences of influenza virus infection on cyclin D3 expression levels, we infected A549 cells for increasing time points and MOI and analyzed protein levels by western blotting. We found that level of expressed cyclin D3 is decreased upon infection and that this effect is dependent on both time of infection and MOI used. Those data suggest that cyclin D3 is either degraded or its expression down regulated upon influenza virus infection. Interestingly, protein levels of downstream effectors, namely cyclin dependent kinases CDK4 and 6, retinoblastoma protein RB, and cyclin E and A, were also diminished upon infection. By contrast, levels of the CDK inhibitors P15 and P16, which are upstream regulators of the G1-S transition, were unchanged. Together, our data strongly suggest that influenza virus infection alters normal cell cycle progression by interfering with expression levels of cell cycle regulators. Most likely, the newly identified interaction between influenza M2 proton channel and cyclin D3 is involved in this process. We will further investigate the effects of infection on the cell cycle progression by flow cytometry and decipher the molecular mechanism responsible for the down-regulation of cell cycle regulators in influenza infected cells. We will determine whether alteration of cell cycle progression is a strategy used by influenza virus to better replicate in host cells.

Identification of Cellular Proteins Interacting with Influenza A Virus PB1-F2 Protein

Mrna Display with Library of Even-Distribution Reveals Cellular Interactors of Influenza Virus NS1

Influenza A virus protein PB1-F2 impairs innate immunity by inducing mitophagy

The influenza virus PB2 protein evades antiviral innate immunity by inhibiting JAK1/STAT signalling

Identification of a Novel Viral Protein Expressed from the PB2 Segment of Influenza A Virus

The PB1 protein of influenza A virus inhibits the innate immune response by targeting MAVS for NBR1-mediated selective autophagic degradation

Comparative Influenza Protein Interactomes Identify the Role of Plakophilin 2 in Virus Restriction

Protein-protein Interactions of the Baculovirus Per Os Infectivity Factors (pifs) in the PIF Complex.

Identification of a short sequence motif in the influenza A virus pathogenicity factor PB1-F2 required for inhibition of human NLRP3

Proteomic Analysis at the Subcellular Level for Host Targets Against Influenza A Virus (H1N1)

The Influenza Virus Protein PB1-F2 Increases Viral Pathogenesis through Neutrophil Recruitment and NK Cells Inhibition

Phosphatidylinositol 4,5-Bisphosphate Mediates the Co-Distribution of Influenza A Hemagglutinin and Matrix Protein M1 at the Plasma Membrane

The K526R substitution in viral protein PB2 enhances the effects of E627K on influenza virus replication

Identification of a Novel Interaction Between the M2 Proton Channel of Influenza A Virus and Cyclin D3: Consequences for Cell Cycle Progression

BAG6 inhibits influenza A virus replication by inducing viral polymerase subunit PB2 degradation and perturbing RdRp complex assembly

Computational Studies On The Substrate Interactions Of Influenza A Virus Pb2 Subunit

Analysis of the Interactions Among Baculovirus Per Os Infectivity Factors (PIFs)

Influenza PB1-F2 Inhibits Avian MAVS Signaling

Virus subtype-specific suppression of MAVS aggregation and activation by PB1-F2 protein of influenza A (H7N9) virus

Human Annexin A6 Interacts with Influenza a Virus Protein M2 and Negatively Modulates Infection.

Interaction of NS2 with AIMP2 Facilitates the Switch from Ubiquitination to SUMOylation of M1 in Influenza A Virus-Infected Cells.